EFTA01447222.txt Text dataset_10 View on DOJ

Illegal Activity
none
Blackmail
none
Date
2014-04-23
Document Type
email
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:42
Summary
Tazia Smith updates Jeffrey on his biotech investments, noting positive earnings for Gilead and Biogen's performance. She also reminds him about the expiration of his SY 102.5 call and discusses options related to yen weakness.
Metadata
Subject
WY and Biotech K1
Sender
Tazia Smith
Recipients
jeevacation@gmail.com
Document ID
DB-SDNY-0 101788 SDNY_GM_00247972
Date
2014-04-23
Relationships 3
Entity 1RelationshipEntity 2Description
Tazia Smith business Jeffrey Tazia Smith is providing Jeffrey with information about his biotech basket and investment options.
Nav Gupta business Jeffrey Nav Gupta will email Jeffrey directly to highlight entry points on a trade.
Vinit Sahni business Jeffrey Vinit Sahni is involved in the discussion about weaker-yen iterations.
Notable Quotes 2
Just posting you on your biotech basket - earnings a positive catalyst reversing that downtrend in Gilead.
Just a reminder that your SY 102.5 call is going to expire 5/1.
Financial Information
Amounts:$310$303
Assets:
  • Biotech basket
  • SY 102.5 call
  • Zero-cost option
Transactions:
  • Biotech basket earnings
  • SY 102.5 call expiring 5/1
  • Zero-cost option for some exposure to yen weakness
Raw Analysis JSON click to expand
Themes
Financial transactions/money flowBusiness dealingsCommunications/correspondence
Organizations 7
DB Securities IncDeutsche Asset & wealth managementPershingLAXBloombergGileadBiogen
Locations 2
New York, NY, USA345 Park Avenue, 10154-0004 New York, NY, USA
Text Analysis
Tone
Professional
Purpose
To update Jeffrey on his biotech investments and discuss options related to yen weakness.
Significance
Provides insight into Jeffrey's investment portfolio and the advice he is receiving from financial professionals.
File Info
File Name
EFTA01447222.txt
Dataset
dataset_10
Type
Text
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:42:32.719713
DOJ Source
View on DOJ